德维喜DOVC品牌怎么样 申请店铺

更新时间:2024-10-26
德维喜DOVC是哪个国家的品牌?「德维喜DOVC」是 东北制药集团股份有限公司 旗下著名品牌。该品牌发源于辽宁省沈阳市,由创始人魏海军在1993-06-10期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
德维喜DOVC怎么样

创始于1993年,知名维生素品牌,覆盖医药研发、制造、分销全产业链条,以化学原料药为主的大型综合性制药企业


东北制药集团股份有限公司(简称“东北制药”,股票代码:000597),是辽宁方大集团实业有限公司(简称“方大集团”)旗下上市公司。公司前身为东北制药总厂,始建于1946年,曾援建全国19省市52家医药企业,向外输送干部1300多人。

目前,东北制药拥有化学原料药、化学制剂、医药商业、医药工程、生物医药等主要业务板块,覆盖医药研发、制造、分销全产业链条,员工队伍9300余人,总资产120亿元。公司主要生产维生素系列药品、抗感染系统用药、妇产科系统用药、消化系统用药、泌尿系统用药、抗病毒系列用药、心脑血管系列用药、镇痛镇咳系列用药、生物诊断系列、大健康领域系列等十大系列精品,400多种化学原料药、医药中间体和制剂产品,主导产品远销100多个国家和地区。

公司拥有强大的产品制造体系。制剂生产基地占地18万平方米,拥有生产线30余条,年产能100亿片(支、丸、粒、枚、瓶)。原料药生产基地占地91万平方米,是国家大宗原料药和医药中间体智能制造示范工厂,主要产品包括维生素C及系列、左旋肉碱系列、磷霉素系列、吡拉西坦、卡前列甲酯、金刚烷胺、硫糖铝、黄连素、氯霉素等,并向下游东北制药制剂产业链延伸,形成难以复制的综合竞争优势。

东北制药不仅是中国重要的药品生产与出口基地,还设有药物研究院、工程设计公司、装备制造安装公司、国际贸易公司、计量检测公司、危化品运输公司等各独立业务公司。

东北制药医药商业业务网络覆盖辽宁全部地级市县,并向东北三省延伸,东北大药房拥有百余家连锁店,医药电商业务实现线上线下一体化,商业模式创新持续推进。


Founded in 1993, it is a well-known vitamin brand, covering the whole industrial chain of pharmaceutical research and development, manufacturing and distribution. Northeast Pharmaceutical Group Co., Ltd., a large comprehensive pharmaceutical enterprise mainly engaged in chemical APIs (hereinafter referred to as "Northeast Pharmaceutical", stock code: 000597), is a listed company under Liaoning Fangda Group Industry Co., Ltd. (hereinafter referred to as "Fangda group"). The company, formerly known as the Northeast Pharmaceutical General Factory, was founded in 1946. It has assisted in the construction of 52 pharmaceutical enterprises in 19 provinces and cities across the country, and has sent more than 1300 cadres. At present, Northeast Pharmaceutical has major business sectors such as chemical APIs, chemicals, pharmaceutical commerce, pharmaceutical engineering, biomedicine, covering the whole industrial chain of pharmaceutical research and development, manufacturing, distribution, with more than 9300 employees and a total asset of 12 billion yuan. The company mainly produces ten series of high-quality products, including vitamin series, anti infection system medicine, gynecology and obstetrics system medicine, digestive system medicine, urinary system medicine, anti-virus series medicine, cardiovascular and cerebrovascular series medicine, analgesia and antitussive series medicine, biological diagnosis series, large health field series, more than 400 kinds of chemical APIs, pharmaceutical intermediates and preparation products, leading products It is exported to more than 100 countries and regions. The company has a strong product manufacturing system. The preparation production base covers an area of 180000 square meters, with more than 30 production lines and an annual production capacity of 10 billion tablets (pills, granules, tablets, bottles). The API production base covers an area of 910000 square meters. It is a national bulk API and pharmaceutical intermediate intelligent manufacturing demonstration factory. Its main products include vitamin C and series, L-carnitine series, fosfomycin series, piracetam, carboprost methyl ester, amantadine, sucralfate, berberine, chloramphenicol, etc. and it extends to the downstream Northeast Pharmaceutical industry chain, forming a hard to replicate Comprehensive competitive advantage. Northeast Pharmaceutical is not only an important pharmaceutical production and export base in China, but also has independent business companies such as pharmaceutical research institute, engineering design company, equipment manufacturing and installation company, international trade company, measurement and testing company, dangerous chemicals transportation company, etc. The Northeast Pharmaceutical business network covers all prefecture level cities and counties in Liaoning, and extends to three provinces in Northeast China. The Northeast pharmacy has more than 100 chain stores. The online and offline integration of pharmaceutical e-commerce business is realized, and the innovation of business model is continuously promoted.

本文链接: https://brand.waitui.com/aa403ad85.html 联系电话:02425806688

千城特选小程序码

7×24h 快讯

特斯拉晋升迈克尔·斯奈德为能源与充电副总裁

10月26日,职业社交网站LinkedIn显示,特斯拉Megapack高级总监迈克尔·斯奈德(Michael Snyder)已获晋升为能源与充电副总裁。斯奈德于2014年6月加入特斯拉,于2022年8月担任Megapack高级主管,领导公司的Megapack项目。(界面)

29分钟前

机构:三季度全球AMOLED手机面板出货量同比、环比双增长

36氪获悉,10月26日,CINNO Research最新报告指出,随着苹果iPhone16系列等高端旗舰机型的发布,第三季度OLED面板的整体需求持续回升。根据CINNO Research统计数据显示,2024年第三季度全球AMOLED智能手机面板出货量约2.2亿片,同比增长25.3%,环比增长0.9%,同比、环比双增长。从柔性面板出货来看,2024年第三季度全球AMOLED智能手机面板中柔性AMOLED智能手机面板占比76.4%,同比下滑2.3个百分点,环比上升4.2个百分点。

29分钟前

上海机场明日将执行2024年冬春航班计划

36氪获悉,据上海机场集团消息,2024年10月27日至2025年3月29日,上海机场将执行2024年冬春航季航班计划。新航季中,上海机场日均计划执行航班2403架次(其中,浦东机场1627架次、虹桥机场776架次)。日均计划执行国内客运航班1646架次(其中,浦东机场915架次、虹桥机场731架次),同比持平;日均计划执行国际、港澳台客运航班561架次(其中,浦东机场516架次,虹桥机场45架次),同比增长5.2%。

29分钟前

加“新能源”减“红利”,公募基金进攻路线图显现

10月25日,公募基金2024年三季报披露完毕。公募基金最新前十大重仓股出炉,分别是宁德时代、贵州茅台、腾讯控股、立讯精密、美的集团、五粮液、紫金矿业、中际旭创、阳光电源、比亚迪。与2024年二季度末相比,阳光电源、比亚迪新进前十大重仓股,中国海洋石油、迈瑞医疗则退出前十大重仓股行列。随着市场在三季度末快速上涨,基金经理操作更为积极,调仓动作明显。整体来看,公募基金加仓了多只新能源龙头股,同时减持了前期涨幅较高的红利个股。(中证网)

29分钟前

哪吒汽车马来西亚首家旗舰店开业

36氪获悉,2024年10月25日,哪吒汽车马来西亚首家旗舰店在吉隆坡隆重开业,当日首批50位车主现场交付。据了解,今年,马来西亚赶超泰国,成为仅次于印度尼西亚的东南亚第二大汽车市场。作为在东南亚广受欢迎的中国造车新势力品牌,哪吒汽车正迅速扩大马来西亚新能源汽车市场,目前已拥有12家经销商,并计划在2024年底前,将经销商网络扩大至20家。另外,哪吒汽车在马来西亚的本地工厂,预计明年正式投产。

29分钟前

本页详细列出关于德维喜DOVC的品牌信息,含品牌所属公司介绍,德维喜DOVC所处行业的品牌地位及优势。
咨询